Predictive model for the length of hospital stay of children with hematologic malignancies, neutropenia, and presumed infection

Journal of Pediatric Hematology/Oncology

Volumn 26, Issue 12, 2004, Pages 813-816

  Cardoso Pastura, Patricia Souza Valle ^a,b   Land, Marcelo G P ^a   Santoro Lopes, Guilherme ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Federal University of Rio de Janeiro ^*  (Brazil)

Author keywords

Children; Hematologic malignancies; Infection; Length of stay; Neutropenia

Indexed keywords

ADOLESCENT; AGE; ARTICLE; CANCER RECURRENCE; CENTRAL VENOUS CATHETER; CHILD; CHILD HOSPITALIZATION; FEMALE; HEMATOLOGIC MALIGNANCY; HOSPITAL ADMISSION; HUMAN; INFECTION; LENGTH OF STAY; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PHYSICAL EXAMINATION; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR;

AGE FACTORS; CATHETERIZATION, CENTRAL VENOUS; CHILD; CHILD, PRESCHOOL; FEMALE; FORECASTING; HEMATOLOGIC NEOPLASMS; HOSPITALIZATION; HUMANS; INFECTION; LENGTH OF STAY; MALE; MODELS, THEORETICAL; MULTIVARIATE ANALYSIS; NEUTROPENIA; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS;

EID: 10944227769     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Schimpff S, Satterlee W, Young VM, et al. Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. N Engl J Med. 1971;284:1061-1065.
2. Hughes WT, Armstrong D, Bodey GP, et al. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Clin Infect Dis. 1997;25:551-573.
3. Hughes WT, Armstrong D, Bodey GP, et al. Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis. 2002;34:730-751.
4. Rahiala J, Perkkiö M, Riikonen P. Infections occurring during the courses of anticancer chemotherapy in children with ALL: a retrospective analysis of 59 patients. Pediatr Hematol Oncol. 1998;15:165-174.
5. Lucas KG, Brown AE, Armstrong D, et al. The identification of febrile, neutropenic children with neoplastic disease at low-risk for bacteremias and complications of sepsis. Cancer. 1996;77:791-798.
6. Petrilli AS, Melaragno R, Barros KVT, et al. Fever and neutropenia in children with cancer: a therapeutic approach related to the underlying disease. Pediatr Infect Dis J. 1993;12:916-921.
7. Rosenman M, Madsen K, Hui S, et al. Modeling administrative outcomes in fever and neutropenia: clinical variables significantly influence length of stay and hospital charges. J Pediatr Hematol Oncol. 2002;24:263-268.
8. Jackson MA, Swanson DS. Infectious complications in the neutropenic patient. Semin Pediatr Infect Dis. 2000;11:90-96.
9. Hann I, Viscolli C, Paesmans M, et al. A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. European Organization for Research on Treatment of Cancer International Antimicrobial Therapy Cooperative Group. Br J Haematol. 1997;99:580-588.
10. Duan N. Smearing estimate: a non-parametric retransformation method. J Am Stat Assoc. 1983;78:605-610.
11. Harms D, Gortitz I, Lambrecht W, et al. Infectious risks of Broviac catheters in children with neoplastic diseases: a matched pairs analysis. Pediatr Infect Dis J. 1992;11:1014-1018.
12. Rackoff WR, Ge J, Sather HN, et al. Central venous catheter use and the risk of infection in children with acute lymphoblastic leukemia: a report from the Children's Cancer Group. J Pediatr Hematol Oncol. 1999;21:260-267.
13. Jones GR, Konsler GK, Dunaway RP, et al. Infection risk factors in febrile, neutropenic children and adolescents. Pediatr Hematol Oncol. 1996;13:217-229.
14. Talcott JA, Finberg R, Mauer RJ, et al. The medical course of cancer patients with fever and neutropenia: clinical identification of a low-risk subgroup at presentation. Arch Intern Med. 1988;148:2561-2568.
15. Lehrnbecher T, Foster C, Vasquez N, et al. Therapy-induced alterations in host defense in children receiving therapy for cancer. J Pediatr Hematol Oncol. 1997;19:399-417.
16. Mackall C, Fleister T, Brown M, et al. Age thymopoesis and CD4+ T-lymphocyte regenerations after intensive chemotherapy. N Engl J Med. 1995;332:143-149.
17. Klaassen RJ, Goodman TR, Pham B, et al. Low-risk prediction rule for pediatric oncology patients presenting with fever and neutropenia. J Clin Oncol. 2000;18:1012-1019.
18. Santolaya ME, Alvarez AM, Becker A, et al. Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia and fever. J Clin Oncol. 2001;19:3415-3421.
19. Aquino VM, Tkaczewski I, Buchanan GR. Early discharge of low-risk febrile neutropenic children and adolescents with cancer. Clin Infect Dis. 1997;25:74-78.